Richard Pasternak
Director/Board Member bij MILESTONE PHARMACEUTICALS INC.
Vermogen: 17 900 $ op 31-03-2024
Profiel
Richard C.
Pasternak is currently an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. He also holds director positions at American Heart Association, Inc., Magenta Medical Ltd., Galien Foundation, Association of Black Cardiologists, Anthos Therapeutics, Inc., Haptocure Ltd., and Weill Cornell Medical College.
In his former roles, Dr. Pasternak served as the Chairman & Chief Executive Officer of Cerenis Therapeutics, Inc. from 2011 to 2019.
He was also the Chairman of ABIONYX Pharma SA in 2019.
Additionally, he held director positions at Beth Israel Hospital, The General Hospital Corp., Essentialis, Inc., and Merck & Co., Inc. He was an Associate Professor at Harvard Medical School.
Dr. Pasternak completed his undergraduate and doctorate degrees at Yale University in 1971 and 1974, respectively.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-06-2023 | 10 000 ( 0.02% ) | 17 900 $ | 31-03-2024 |
Actieve functies van Richard Pasternak
| Bedrijven | Functie | Begin |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Director/Board Member | 11-11-2019 |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Director/Board Member | - |
| Galien Foundation | Director/Board Member | - |
Magenta Medical Ltd.
 Magenta Medical Ltd. Medical SpecialtiesHealth Technology Magenta Medical Ltd. develops medical devices for the treatment of acute and congestive heart failure. It offers a temporary venous catheter-based therapy for hospital-admitted patients. The firm?s novel therapeutic principle is aimed at addressing renal venous congestion and its deleterious effects on renal and cardiac function that is a pathophysiological core element of acute heart failure. The company was founded by Ehud Schwammenthal and Yosi Tuval in October 2012 and is headquartered in Kadima, Israel. | Director/Board Member | - |
Association of Black Cardiologists
 Association of Black Cardiologists Miscellaneous Commercial ServicesCommercial Services The Association of Black Cardiologists (ABC) was founded in 1974 by Richard Allen Williams and 17 other medical professionals. The organization is based in New York, NY. The organization aims to save the hearts and minds of a diverse America. ABC provides access to clinical studies for investigators from multiple specialties through its clinical research network (ABC CRN). Recently, ABC has been involved in COVID-19 webinars and anti-racism training. | Director/Board Member | - |
| Weill Cornell Medical College | Corporate Officer/Principal | - |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Director/Board Member | 01-01-2019 |
| Haptocure Ltd. | Director/Board Member | - |
Eerdere bekende functies van Richard Pasternak
| Bedrijven | Functie | Einde |
|---|---|---|
| ABIONYX PHARMA | Chief Executive Officer | 06-09-2019 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Richard Pasternak
| Yale University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| ABIONYX PHARMA | Health Technology |
| Bedrijven in privébezit | 10 |
|---|---|
Beth Israel Hospital
 Beth Israel Hospital Medical/Nursing ServicesHealth Services Beth Israel Hospital provides healthcare services. The private company is based in Boston, MA. | Health Services |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
Essentialis, Inc.
 Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Essentialis, Inc. develops therapeutic products in curing metabolic diseases. It operates as a pharmaceutical company focusing on the development of breakthrough medicines for the treatment of rare metabolic diseases where there is mortality and risk of cardiovascular and endocrine complications. The company was founded by Neil M. Cowen, Jeffrey A. Staffa and Thomas A. Glaze in 2004 and is headquartered in San Diego, CA. | Health Technology |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | Health Technology |
Magenta Medical Ltd.
Magenta Medical Ltd. Medical SpecialtiesHealth Technology Magenta Medical Ltd. develops medical devices for the treatment of acute and congestive heart failure. It offers a temporary venous catheter-based therapy for hospital-admitted patients. The firm?s novel therapeutic principle is aimed at addressing renal venous congestion and its deleterious effects on renal and cardiac function that is a pathophysiological core element of acute heart failure. The company was founded by Ehud Schwammenthal and Yosi Tuval in October 2012 and is headquartered in Kadima, Israel. | Health Technology |
| Galien Foundation | |
Association of Black Cardiologists
Association of Black Cardiologists Miscellaneous Commercial ServicesCommercial Services The Association of Black Cardiologists (ABC) was founded in 1974 by Richard Allen Williams and 17 other medical professionals. The organization is based in New York, NY. The organization aims to save the hearts and minds of a diverse America. ABC provides access to clinical studies for investigators from multiple specialties through its clinical research network (ABC CRN). Recently, ABC has been involved in COVID-19 webinars and anti-racism training. | Commercial Services |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Health Technology |
| Haptocure Ltd. |
